financetom
Business
financetom
/
Business
/
Paychex to Buy Paycor HCM For $4.1 Billion in Bid to Expand Upmarket, Advance AI Capabilities
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Paychex to Buy Paycor HCM For $4.1 Billion in Bid to Expand Upmarket, Advance AI Capabilities
Jan 7, 2025 10:24 AM

01:12 PM EST, 01/07/2025 (MT Newswires) -- Paychex ( PAYX ) struck a deal to buy Paycor HCM ( PYCR ) in a $4.1 billion deal that will help the human resources and payroll solutions provider expand upmarket and boost its artificial intelligence capabilities.

The cash consideration of $22.50 per share represents a premium of 19% over Paycor's 30-day average price as of the unaffected trading date of Jan. 3, according to a statement released Tuesday. Shares of Paycor fell 3.1% midday trade while Paychex's ( PAYX ) rose 2.3%.

Human capital management company Paycor has about 2,900 employees that serve more than 49,000 clients and support roughly 2.7 million employees across the US. Paycor's investments in data, AI and other technologies since going public in 2021 have helped expand its upmarket position, the companies said.

"The acquisition of Paycor is highly complementary," Paychex ( PAYX ) Chief Executive John Gibson said. "It will enhance our capabilities upmarket, broaden our suite of AI-driven HR technology capabilities, and provide new channels for sustained long-term growth."

Paycor is majority owned by Apax Partners, which acquired its stake in November 2018. The company has tripled in size since Apax's original investment, Jason Wright, partner at Apax and Paycor board chair, said in a separate statement.

The companies' combined offering will be one of the most comprehensive in the industry while run-rate cost synergies are expected to exceed $80 million in the near term. In years following close, the companies project a "substantial revenue synergy opportunity."

The transaction is expected to close in the first half of 2025, pending regulatory approvals. Paychex ( PAYX ) plans to fund the acquisition with incremental debt and has obtained committed financing.

"We are confident that our customers will benefit from the shared expertise, resources, and innovative (human capital management) solutions of both companies to drive even greater people and business performance," said Paycor CEO Raul Villar Jr.

Price: 139.36, Change: +3.30, Percent Change: +2.43

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Ultralife Corporation To Acquire Electrochem Solutions
BRIEF-Ultralife Corporation To Acquire Electrochem Solutions
Oct 2, 2024
Sept 30 (Reuters) - Ultralife Corporation ( ULBI ) : * ULTRALIFE CORPORATION TO ACQUIRE ELECTROCHEM SOLUTIONS, INC. * ULTRALIFE CORP ( ULBI ) - TO ACQUIRE ELECTROCHEM SOLUTIONS FOR $50 MILLION * ULTRALIFE CORP ( ULBI ) - TRANSACTION EXPECTED TO BE ACCRETIVE ON EPS BASIS FOR 2025 Source text for Eikon: Further company coverage: ...
Reklaim Announces Normal Course Issuer Bid
Reklaim Announces Normal Course Issuer Bid
Oct 2, 2024
07:49 AM EDT, 09/30/2024 (MT Newswires) -- Reklaim ( MYIDF ) on Monday said the TSX Venture Exchange has approved the company's notice of intention to buy back up to 7.8 million of its common shares, comprising 10% of its public float. The buyback will start Monday, September 30, and run for one year. Reklaim ( MYIDF ) operates in...
What's Going On With Stellantis Stock Monday?
What's Going On With Stellantis Stock Monday?
Oct 2, 2024
Stellantis NV ( STLA ) stock is plunging Monday after it revised its fiscal 2024 guidance to reflect its remediation actions on North American performance issues and deterioration in global industry dynamics. Auto rivals, including General Motors Co ( GM ) and Ford Motor Co ( F ) , are trading lower in sympathy with Stellantis ( STLA ). The company projects...
CVS Health in Focus as Activist Investor Prepares for High-Level Talks
CVS Health in Focus as Activist Investor Prepares for High-Level Talks
Oct 2, 2024
CVS Health Corp ( CVS ) is set to face renewed pressure as hedge fund Glenview Capital Management, led by founder Larry Robbins, plans to meet top executives, including CEO Karen Lynch, to discuss operational improvements. The meeting with Glenview comes as part of Robbins’ broader strategy to push for change, the Wall Street Journal reports. Also Read: Pharmacy Chains...
Copyright 2023-2026 - www.financetom.com All Rights Reserved